Are you a patient just learning about your antibodies? Start here for an introduction to what is happening in your body.
Start HereAre you a provider looking for the most current, evidence-based guidelines for the management of alloimmunized pregnancies?
Learn MoreThe Allo Hope Foundation and AllStripes are partnering to create a database that will enable multiple Alloimmunization & HDFN research projects! We’re looking for patients/families willing to contribute their de-identified medical records to make this effort as strong as possible. Your medical journey can accelerate the development of new treatment and monitoring methods for alloimmunization & HDFN. Because these are rare conditions, researchers need more information directly from patients and their families to fully understand the condition.
The Prenatal Decision Tree can be used as a step by step guide through the proper course of prenatal care for alloimmunized patients according to current medical literature. If your care plan differs from this, discuss it with your physicians and seek a second opinion if needed. For additional references and a more in-depth explanation of the information in this tree, please see our Providers page.
A history of alloimmunization from the 1600s to present. Discover the advances in testing, treatment, and outcomes for patients with Hemolytic Disease of the Fetus and Newborn (HDFN) over the past 400 years.
Journey with our families as they go through pregnancy dealing with alloimmunization and HDFN.
Disclaimer: The purpose of this website is to provide general education, access to resources, and relevant literature. This website does not provide specific medical advice or recommendations for individual patients and is not a substitute for speaking with qualified healthcare professionals. The Allo Hope Foundation strongly recommends that care and treatment related to alloimmunization and HDFN be made in consultation with your physicians who are familiar with your individual health situation.
Our mission is to prevent any harm, stillbirth or infant death caused by alloimmunization and HDFN. We are dedicated to providing patient advocacy, support and education while promoting research and improving healthcare practices for the condition.